• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

InspireMD

InspireMD wins FDA approval for carotid stent system study

September 8, 2020 By Danielle Kirsh

InspireMD today said it received FDA approval to proceed with a pivotal study of its CGuard Carotid Stent System. The investigational device exemption from the FDA will allow the company to study the device for the prevention of stroke in patients in the U.S. Get the full story on our sister site, Medical Tubing + […]

Filed Under: Food & Drug Administration (FDA), Stents, Vascular Tagged With: InspireMD

InspireMD posts Street-beating Q2 results

August 7, 2020 By Danielle Kirsh

InspireMD (NYSE:NSPR) posted second-quarter results today that beat the consensus on Wall Street. The Tel Aviv, Israel-based company reported losses of $2.5 million, on sales of $313,000 for the three months ended June 30, for a sales loss of -76.9% compared with Q2 2019. Earnings per share were -20¢, 15¢ ahead of The Street, where analysts […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: InspireMD

InspireMD raises $10.7m

June 8, 2020 By Sean Whooley

InspireMD (NYSE:NSPR)  announced today that it entered into an underwriting agreement to raise $10.7 million. According to a news release, InspireMD entered into the underwriting agreement on June 3 with A.G.P./Alliance Global Partners in the offering of more than 7.6 million units consisting of one share of InspireMD’s common stock and one Series F warrant to […]

Filed Under: Business/Financial News, Funding Roundup, Vascular, Wall Street Beat Tagged With: InspireMD

Barry out as InspireMD CEO

December 10, 2019 By Nancy Crotti

InspireMD (NYSE:NSPR) announced today that president & CEO James Barry is stepping down, effective Dec. 31, to pursue other opportunities. InspireMD is facing a potential de-listing from the New York Stock Exchange after reporting stockholders’ equity of less than $6 million as of June 30 and net losses for the last five years. The company […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Wall Street Beat Tagged With: InspireMD

Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019

September 26, 2019 By Brad Perriello

Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]

Filed Under: Featured, Funding Roundup, Wall Street Beat Tagged With: Cadence Neuroscience, DiagnosisONE, eko, Healionics, InspireMD, Kheiron Medical Technologies, Neuromod Devices, Profound Medical Inc., provisio

InspireMD registers $6m offering

August 27, 2019 By Sean Whooley

InspireMD (NYSE:NSPR) last week registered for an offering worth more than $6 million for its MicroNet stent platform. MicroNet is a micron mesh sleeve that’s designed to wrap a stent and provide embolic protection in the treatment of complex vascular and coronary disease. InspireMD used the platform to develop the CGuard carotid embolic prevention system, […]

Filed Under: Funding Roundup, Stents, Vascular, Wall Street Beat Tagged With: InspireMD, Securities & Exchange Commission (SEC)

InspireMD pulls the trigger on another reverse stock split

March 29, 2019 By Fink Densford

InspireMD (NYSE:NSPR) said this week its stockholders approved a 1-for-50 reverse split of its stock, slated to take effect today. The reverse split comes only 13 months after its last 1-for-35 reverse split, which the Israel-based company initiated last February. Through the deal, each shareholder in the company will receive a single share of the company’s […]

Filed Under: Business/Financial News, Featured, Wall Street Beat Tagged With: InspireMD

InspireMD touts results of ‘one-size-fits-all’ stroke-prevention study

January 28, 2019 By Nancy Crotti

A clinical trial of  InspireMD’s (NYSE:NSPR) CGuard embolic prevention stent showed that it successfully treated patients whose carotid arteries varied in size, according to the company. The investigator-initiated trial in Germany used a 10 mm diameter CGuard stent with SmartFit technology across a broad range of carotid artery diameters. Variations in diameters of the common carotid artery (CCA) […]

Filed Under: Clinical Trials, Implants, Neurological, News Well, Research & Development, Stents Tagged With: InspireMD

InspireMD inks distro deal for CGuard in South Africa

January 14, 2019 By Sarah Faulkner

InspireMD (NYSE:NSPR) said today that it inked a deal with Torque Medical to distribute its CGuard Embolic Prevention System in South Africa. The Israel-based company reported that it will begin the commercial launch for CGuard in South Africa immediately. “We are extremely pleased with the opportunity to offer CGuard EPS in the South African market. We […]

Filed Under: Business/Financial News, Distribution, Featured, Vascular, Wall Street Beat Tagged With: InspireMD

InspireMD touts results of next-gen stroke prevention stent study

December 24, 2018 By Nancy Crotti

InspireMD (NYSE:NSPR) has released the results of a meta-analysis of four clinical studies involving dual-layered (DLS) and mesh-covered stents, including the company’s MicroNet-covered stent, the CGuard embolic prevention system. The analysis concluded that carotid artery disease patients treated with mesh-covered stents experienced a 30-day minor stroke rate of 1.25%, lower than the 30-day minor stroke rates reported in […]

Filed Under: Cardiovascular, Research & Development, Stents Tagged With: InspireMD, Terumo

InspireMD wins regulatory nod in Ecuador for CGuard, MGuard

May 18, 2018 By Fink Densford

InspireMD (NYSE:NSPR) said this week it won regulatory approval in Ecuador for its CGuard embolic prevention system and MGuard Prime devices. The approval comes shortly after the company inked an exclusive distribution agreement with Ecuadorian medical device distributor Cardiobene, Israel-based InspireMD said. Both companies have worked together to secure regulatory approvals in the country, InspireMD added. “We […]

Filed Under: Catheters, Neurological, Regulatory/Compliance, Vascular Tagged With: InspireMD

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS